Orloff, Marlana

University of Liverpool · Thomas Jefferson University Hospital · University Hospital Heidelberg · Princess Margaret Cancer Centre · Clatterbridge Cancer Centre NHS Foundation Trust · Sidney Kimmel Cancer Center · Mount Vernon Cancer Centre · National Center for Tumor Diseases

2 papers on CoChatORCID 0000-0001-9460-2587

Most cited papers

Verified
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Nathan, P., Hassel, J. C., Rutkowski, P., Baurain, J.-F., Butler, M. O., Schlaak, M., Sullivan, R. J., Ochsenreither, S., Dummer, R., Kirkwood, J. M., et al. (2021) · New England Journal of Medicine
Ocular Oncology and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 924
Verified
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects
Dalvin, L. A., Shields, C. L., Orloff, M., Sato, T., & Shields, J. A. (2018) · Retina
Cancer Immunotherapy and BiomarkersDrug-Induced Ocular Toxicity
Cited by 336

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free